
Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early

Should we be double masking?
UC Riverside epidemiologist answers this and other questions in Q&A

Biomedical scientist explains how Covid-19 vaccines work
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines

Are people living with HIV more isolated during the pandemic?
A UC Riverside-led study, funded by Merck, is set to find out

School of Medicine to serve as lead site for clinical trial on stuttering
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.

More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population

Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity

Impact of HPV vaccination mandates on social inequalities
Policy has limited impact on vaccine uptake because of individual decision making, study finds

Drug found to correct gene defect that causes immune-driven gut leakiness
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells

Developing a COVID-19 vaccine at warp speed
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside